The University of Toledo
09/08/2026 | Press release | Distributed by Public on 09/08/2026 02:26
UToledo Ph.D. Student Named to ACS Future Pharma Innovator Cohort
UToledo Ph.D. Student Named to ACS Future Pharma Innovator Cohort
Trust Nwaka, a Ph.D. student in the Department of Medicinal and Biological Chemistry at The University of Toledo College of Pharmacy and Pharmaceutical Sciences, has been selected as a member of the 2026 American Chemical Society (ACS) Future Pharma Innovator Cohort. He is one of only 22 Ph.D. candidates chosen from the United States and Canada for the highly competitive program.
Trust Nwaka, a Ph.D. student in the Department of Medicinal and Biological Chemistry, has been selected as a member of the 2026 American Chemical Society Future Pharma Innovator Cohort.
The ACS Future Pharma Innovator program recognizes exceptional emerging scholars who demonstrate strong technical achievement and a commitment to advancing careers in the pharmaceutical industry. Selection into the program is a mark of distinction, identifying participants as among the most promising young researchers in the field.
As a member of the 2026 cohort, Nwaka attended the ACS Fall 2026 Meeting, held Aug. 23-27 in Chicago. During the meeting, cohort members presented their research, engaged in scientific discussions and participated in networking opportunities with peers and industry professionals.
"I am very honored to be selected as one of the awardees of the ACS Future Pharma Innovator 2026 cohort," Nwaka said. "I am deeply grateful to my advisor, Dr. Schiefer, for his continued support and mentorship, and to The University of Toledo for providing an excellent environment that has allowed me to pursue innovative research, grow as a scientist and reach this important milestone."
The award also reflects the strength of graduate research at The University of Toledo and the growing impact of its students in addressing global challenges in healthcare and drug development. Programs such as the ACS Future Pharma Innovator initiative help bridge academic research and industry application, preparing the next generation of leaders in pharmaceutical sciences.
Through participation in the cohort, Nwaka joins a national network of scholars and professionals dedicated to advancing innovation, collaboration and excellence in pharmaceutical research.
The University of Toledo published this content on September 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 08, 2026 at 08:26 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]